THE DATA BEHIND THE BOOK — ORDER DELAY, DENY, DEPOSE — $11.95 →
Every chart on this page is cited, sourced, and updated. This is not opinion — it is the documented record of how American healthcare got here, and where it’s going.
Updated daily. Sourced from KFF Health News, STAT News, ProPublica, and Modern Healthcare.
Updated annually from government sources. Come back every year — these numbers get worse.
Total annual family insurance premium, 1960–2035 (inflation-adjusted)
Total annual premium — employer + employee combined — for a family of four. Inflation-adjusted to 2024 dollars. Most Americans only see their paycheck deduction.
In 1960, the total annual cost of family health insurance was $820 in today's dollars. By 2024 it reached $25,572 — a 31-fold increase after inflation. At current trajectory, the CBO projects the total family premium will exceed $53,000 per year by 2035. Most workers see only their paycheck deduction; the employer's share — roughly 70% of the total — is invisible to them.
Source: KFF Employer Health Benefits Survey (1999–2024); BLS Consumer Expenditure Survey (pre-1999); projection based on CBO actuarial growth assumptions. All figures inflation-adjusted to 2024 USD via BLS CPI.
US healthcare administrative overhead vs. peer nations
Healthcare administrative overhead as a percentage of total health spending. The US spends more on paperwork than most countries spend on actual care.
The United States spends 34.2% of total healthcare expenditure on administration — billing, coding, prior authorization paperwork, and insurer overhead. Canada spends 12.4%. Germany spends 5.3%. The gap between the US and Germany alone accounts for roughly $800 billion per year. This is one of the primary reasons why American healthcare is so expensive despite delivering worse outcomes than peer nations.
Source: CMS National Health Expenditure Data; Himmelstein & Woolhandler, NEJM (2019); Commonwealth Fund international comparisons.
US healthcare spending as % of GDP, 1960–2035
Healthcare as a percentage of US GDP, 1960–2024, with CBO baseline projection to 2035. The dashed line assumes no policy change.
In 1960, the US spent 5% of GDP on healthcare. By 2024, that figure reached 18.0% — more than any other nation on earth. The Congressional Budget Office projects that without policy intervention, healthcare will consume 23.8% of GDP by 2035. No other sector of the American economy has grown at this pace. The cost of US healthcare is not a temporary spike — it is a structural trend with no natural ceiling.
Source: CMS National Health Expenditure Data (historical); CBO Long-Term Budget Outlook (projection, updated annually).
Annual healthcare fraud recovered by DOJ and HHS OIG, 2010–2024
Annual healthcare fraud recovered by DOJ and HHS OIG. Note: recovered fraud is estimated at less than 10% of total fraud committed.
DOJ and HHS OIG recovered $48.1 billion in healthcare fraud between 2010 and 2024. The peak year was 2021 at $5.0 billion recovered. Investigators estimate that recovered fraud represents less than 10% of total fraud committed annually — meaning the actual cost of healthcare fraud to Americans likely exceeds $50 billion per year. This is not rare misconduct; it is a systemic tax built into the cost of American healthcare.
Source: HHS Office of Inspector General Annual Reports; DOJ Criminal Fraud Section.
Medicare per-capita spending by US county — 3,146 counties, CMS 2023 data
Medicare per-capita spending by US county. Spending varies by 2–3x across counties — driven by market concentration, not health outcomes. Hover a county to see its figure.
Medicare per-capita spending across 3,146 US counties ranges from $5,333 to $27,129 per year — a 5x spread driven almost entirely by local market structure, not by patient illness. Counties with high hospital concentration spend dramatically more for the same outcomes. This is the geography of American healthcare: your ZIP code determines your cost more than your diagnosis does.
Source: CMS Geographic Variation in Medicare Spending; Dartmouth Atlas of Health Care.
Annual excess Medicare spending: hospital outpatient billing vs. physician office rates
Total annual excess Medicare spending when procedures are billed as hospital outpatient department (HOPD) visits instead of physician office visits. Same doctor. Same patient. Same procedure. Different address — 80% higher bill.
When a hospital acquires a physician's practice and begins billing the same office visit as a hospital outpatient department (HOPD) visit, Medicare pays roughly 80% more for an identical service. In 2023 alone, this site-of-care billing premium cost Medicare $9.1 billion in excess payments. The trend has grown every year since 2010 (except 2020). This is why hospitals buy clinics — not to improve care, but to qualify for higher billing rates.
Source: MedPAC March Report to Congress (annual, Chapter 2 — Outpatient hospital services); CMS Outpatient Prospective Payment System final rules.
The eight policy decisions that built the most expensive healthcare system in the world. Each one has a year, an origin, and data showing what it cost you.
Employer-sponsored insurance as % of US coverage, 1940–2024
Employer-sponsored insurance as a share of total US coverage, 1940–2024. A wartime wage freeze in 1942 — nobody voted for this.
In 1940, just 9% of Americans had employer-sponsored health insurance. A 1942 wartime wage freeze — designed to stop inflation, never intended as health policy — allowed companies to compete for workers by offering tax-free health benefits instead of raises. By 1980, employer-sponsored insurance covered 70% of Americans. Today it covers 53%, still the dominant form of coverage — and still entirely dependent on keeping your job.
Source: KFF Employer Health Benefits Survey; Census Bureau health insurance historical data.
US healthcare spending as % of GDP, 1960–2024
US healthcare spending as a percentage of GDP, 1960–2024. Fee-for-service reimbursement rewards volume, not outcomes.
When Medicare launched in 1965, US healthcare spending stood at 5% of GDP — roughly in line with peer nations. The fee-for-service payment model baked into Medicare's original design paid providers for each procedure performed, creating a direct financial incentive to do more. By 2024, spending reached 18.0% of GDP. No peer nation comes close. The volume-based payment structure — not the population's health — is the primary driver of this divergence.
Source: CMS National Health Expenditure Data.
of denied patients actually appeal. The system relies on your exhaustion.
Health insurance claim denial rates by insurer — ACA marketplace plans, 2023
Claim denial rates by major insurer in ACA marketplace plans. Most people give up when denied. That's the business model.
Health insurance claim denial rates in ACA marketplace plans vary widely by insurer: UnitedHealthcare denied 32.9% of claims in 2023, Cigna 25.0%, Aetna 23.9%, Humana 18.4%, and BCBS an average of 14.7%. Despite these denial rates, only 0.1% of denied patients ever file an appeal. Insurers designed the denial process to exploit this exhaustion — most people assume a denial is final when it is not.
Medicare Advantage prior authorization requests and denial rates, 2019–2024
Medicare Advantage prior authorization requests, 2019–2024. The bars show total requests (grey) vs. denials (red). The line shows denial rate — roughly 1 in 25 requests is rejected, and the insurer is counting on most patients to give up rather than appeal.
Medicare Advantage insurers received 54.2 million prior authorization requests in 2024, denying 2.1 million of them. Prior authorization denial volume has grown every year since 2019, when 35.1 million requests were submitted and 1.47 million denied. The denial rate has held steady at roughly 4% — not because insurers are consistent, but because they calibrate the rate to maximize friction without triggering regulatory attention. Each denied request shifts care to the patient to navigate.
Physician practice ownership: independent vs. hospital/corporate employed, 2000–2024
Percentage of physicians in independent practice vs. employed by a hospital or corporate entity, 2000–2024.
In 2000, 57% of US physicians were in independent practice. By 2010, employed physicians outnumbered independent ones for the first time — 51% employed vs. 49% independent. By 2024, just 25% of physicians remain independent; 75% are employed by a hospital, health system, or corporate entity. When your doctor works for a hospital, the hospital's financial incentives — including HOPD billing rates — shape your care. The independent physician who acted as your advocate is nearly extinct.
Medicare payment per office visit: physician office vs. hospital outpatient department (CPT 99213)
Medicare payment for an identical office visit (CPT 99213) at an independent physician office vs. a hospital outpatient department. Same visit. Same doctor. The address changed — and so did the bill. This is why hospitals buy clinics.
For the same Level 3 office visit (CPT 99213) in 2024, Medicare pays $90 at an independent physician office and $205 at a hospital outpatient department — a 128% premium for identical care. This payment gap is the financial engine behind hospital acquisition of physician practices. Hospitals do not buy clinics to improve care. They buy them to reclassify the address and collect the higher HOPD billing rate from Medicare and private insurers alike.
Source: CMS Physician Fee Schedule and Outpatient Prospective Payment System (OPPS) final rules (annual, published November).
Private equity healthcare deal volume (USD billions), 2010–2024
Private equity healthcare deal volume by year, 2010–2024. Sick people can't shop around. Wall Street noticed.
Private equity firms deployed over $1.2 trillion into US healthcare acquisitions between 2010 and 2024. Deal volume peaked in 2021 at $151 billion in a single year. PE firms target physician practices, hospital systems, nursing homes, behavioral health, and dental chains — sectors where patients cannot easily leave or comparison-shop. Research published in JAMA and NEJM consistently links PE acquisition to higher costs, reduced staffing, and worse patient outcomes.
Source: PitchBook private equity healthcare data as cited in JAMA / NEJM academic studies on PE healthcare acquisitions.
Pharmaceutical industry R&D spend vs. marketing and administrative spend, 2010–2023
Pharmaceutical industry R&D spend vs. marketing and administrative spend, 2010–2023. The industry spends more convincing you to buy drugs than it does discovering them.
In 2023, the pharmaceutical industry spent $121 billion on R&D and $112 billion on marketing and administration — an $9 billion gap that has narrowed every year since 2010. In 2010 that gap was $7 billion ($65B R&D vs. $58B marketing). The industry's core claim — that high US drug prices fund innovation — is undermined by the fact that marketing spend has grown proportionally faster than research. The prices are not funding cures; they are funding advertising.
Source: SEC annual filings; OpenSecrets Healthcare Industry Lobbying.
US vs. Canada annual drug prices — same manufacturer, same molecule
Annual cost of 5 common drugs: US price vs. Canada. Same manufacturer. Same molecule. Americans pay 3–10x more — because they can be made to.
The annual cost of Humira in the US is $84,442; in Canada, $15,690 — a 5.4x difference for the identical drug from the same manufacturer. Keytruda costs $191,000 per year in the US vs. $34,200 in Canada. Ozempic: $13,618 in the US vs. $2,532 in Canada. These are not generic vs. brand comparisons. These are the same molecules, the same companies, sold at radically different prices because the US has no mechanism to negotiate drug prices at a national level.
Source: RAND International Prescription Drug Price Comparisons.